REMS & BC Patients

REMS & BC Patients

The use of non-ionizing REMS technology supports longitudinal monitoring in AIs-treated BC patients The study “Longitudinal monitoring of denosumab-associated bone changes by REMS in postmenopausal women with ER-positive breast cancer receiving aromatase inhibitors”,...
Meno costi con REMS

Meno costi con REMS

Abbattimento costi per la diagnosi precoce dell’osteoporosi nelle zone rurali: lo studio Il recente studio pubblicato  dal Journal of Orthopaedic Report, “Advantages of Radiofrequency Echographic Multi Spectrometry (REMS) in evaluating osteoporosis in the rural area...
REMS Performance

REMS Performance

The very recent study titled “Proposed practice parameters for the performance of radiofrequency Echographic multispectrometry (REMS) evaluations” and published on the Bone Joint Open by international key Opinion Leaders from USA and UK showed that REMS are becoming a...
REMS vs DXA

REMS vs DXA

Does Radiofrequency Echographic Multi-Spectrometry (REMS) perform similarly to Dual-energy X-ray Absorptiometry (DXA) in terms of Trabecular Bone Score (TBS) and FRAX? Débora Meira Ramos Amorim, Eliane Naomi Sakane,  Sergio Setsuo Maeda, Marise Lazaretti-Castro....
Studio HTA in USA

Studio HTA in USA

“Cost-effectiveness of radiofrequency echographic multi-spectrometry  for the diagnosis of osteoporosis in the United States:   Jean-Yves Reginster 1, Stuart L. Silverman 2 , Majed Alokail 1, Nasser Al-Daghri 1, Mickael Hiligsmann 3, 1 Bioochemistry...
REMS & Disabilità motoria

REMS & Disabilità motoria

“Radiofrequency echographic multi-spectrometry-based measurement of bone mineral density in patients with severe motor and intellectual disability: An opportunity for patients with severe scoliosis and hip dislocation” (Misurazione della BMD con la...